Výsledky vyhledávání - Azra Durak-Nalbantić
- Zobrazuji výsledky 1 - 4 z 4
-
1
-
2
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) Autor Maciej Banach, Peter E. Penson, Michal Vráblík, Matjaž Bunc, Krzysztof Dyrbuś, Ján Fedačko, Dan Gaiţă, Marek Gierlotka, Zoltán Járai, Stefania Magda, Eduard Margetić, Roman Margoczy, Azra Durak-Nalbantić, Petr Ošťádal, Daniel Pella, Matias Trbušić, C Udroiu, Charalambos Vlachopoulos, Duško Vulić, Zlatko Fras, Dariusz Dudek, Željko Reiner
Vydáno 2021Artigo -
3
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of... Autor Maciej Banach, Željko Reiner, Stanisław Surma, Gani Bajraktari, Agata Bielecka‐Dąbrowa, Matjaž Bunc, Ibadete Bytyçi, R Češka, Arrigo F.G. Cicero, Dariusz Dudek, Krzysztof Dyrbuś, Ján Fedačko, Zlatko Fras, Dan Gaiţă, Dov Gavish, Marek Gierlotka, Robert Gil, Ioanna Gouni‐Berthold, Piotr Jankowski, Zoltán Járai, Jacek Jerzy Jozwiak, Niki Katsiki, Gustavs Latkovskis, Stefania Magda, Eduard Margetić, Roman Margoczy, Olena Mitchenko, Azra Durak-Nalbantić, Petr Ošťádal, György Paragh, Žaneta Petrulionienė, Francesco Paneni, Ivan Pećin, Daniel Pella, Arman Postadzhiyan, Anca Pantea Stoian, Matias Trbušić, C Udroiu, Margus Viigimaa, Dragoş Vinereanu, Charalambos Vlachopoulos, Michal Vráblík, Duško Vulić, Peter E. Penson
Vydáno 2024Artigo -
4
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Rep... Autor Giulia Ferrannini, Dirk De Bacquer, Guy De Backer, Kornelia Kotseva, Linda Mellbin, David Wood, Lars Rydén, Chris P Gale, Branko Beleslin, Andrzej Budaj, Ovidiu Chioncel, Nikolaos Dagres, Nicolas Danchin, David Erlinge, Jonathan Emberson, Michael Glikson, Alastair Gray, Meral Kayıkçıoğlu, Aldo P. Maggioni, Klaudia Vivien Nagy, Aleksandr Nedoshivin, Anna-Sonia Petronio, Jolien W. Roos‐Hesselink, Lars Wallentin, Uwe Zeymer, Kornelia Kotseva, Guy De Backer, Ana Abreu, Carlos Aguíar, Jolita Badarienė, Jan Bruthans, Almudena Castro Conde, Renata Cífková, Jim Crowley, Kairat Davletov, Dirk De Bacquer, Delphine De Smedt, Johan De Sutter, Jaap W. Deckers, Mirza Dilić, Maryna Dolzhenko, H. Druais, Vilnis Dzērve, Andrejs Ērglis, Zlatko Fras, Dan Gaiţă, Nina Gotcheva, Diederick E. Grobbee, Viveca Gyberg, Hosam Hasan Ali, Peter U. Heuschmann, Arno W. Hoes, Piotr Jankowski, Nebojša Lalić, Seppo Lehto, Dragan Lović, S. Mancas, Pedro Marques‐Vidal, Linda Mellbin, Davor Miličić, Erkin М Мirrakhimov, Oganov Rg, Nana Pogosova, Željko Reiner, Lars Rydén, Martin Stagmo, Stefan Störk, Jouko Sundvall, Lâle Tokgözoğlu, Costas Tsioufis, Duško Vulić, David Wood, Arno W. Hoes, Catriona Jennings, Agnieszka Adamska, S. Adamska, L.J. Tuomilehto, Oliver Schnell, Laura Råman, Anne‐Marie Willems, Michel De Pauw, Pieter Vervaet, Jessa Ziekenhuis, J. Bollen, E. Dekimpe, N. Mommen, G. Van Genechten, Paul Dendale, Audrey Bouvier, Patrick Chenu, D. Huyberechts, Alexandre Persu, Alden Begić, Azra Durak-Nalbantić, Alen Džubur, N. Hadzibegic, Amer Iglica, S. Kapidjic, A. Osmanagic Bico, Nerma Resić
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Atherosclerotic cardiovascular disease
Cardiology
Disease
Intensive care medicine
Pathology
Position paper
Cholesterol
Coronary artery disease
Diabetes mellitus
Economics
Ejection fraction
Endocrinology
Eplerenone
Ezetimibe
Finance
Glycated hemoglobin
Glycemic
Heart failure
Impaired glucose tolerance
LDL receptor
Lipoprotein
PCSK9
Pharmacotherapy
Position (finance)
Risk factor
Spironolactone
Statin
Type 2 diabetes